_id
690dac6bccc777a4e85d098c
Ticker
AIRS
Name
Airsculpt Technologies Inc
Exchange
NASDAQ
Address
1111 Lincoln Road, Miami Beach, FL, United States, 33139
Country
USA
Sector
Healthcare
Industry
Medical Care Facilities
Currency
USD
Website
https://airsculpt.com
Description
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
Last Close
3.04
Volume
1049269
Current Price
2.6
Change
-14.473684210526313
Last Updated
2025-11-28T12:03:17.157Z
Image
-
Ipo Date
2021-10-29T00:00:00.000Z
Market Cap
222898912
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.7125
Sentiment Sources
6
Rating
3
Target Price
6
Strong Buy
0
Buy
0
Hold
4
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
34993000
Cost Of Revenue
12064000
Gross Profit
22929000
Operating Expenses
32679000
Operating Income
-9750000
Interest Expense
1407000
Pretax Income
-7867001
Net Income
-9512000
Eps
-0.15800095175972811
Dividends Per Share
0
Shares Outstanding
62436670
Income Tax Expense
1644999
EBITDA
-3243001
Operating Margin
-27.862715400222903
Total Other Income Expense Net
1882999
Cash
5405000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
12218000
Property Plant Equipment
50582000
Total Assets
185920000
Payables
4460000
Short Term Debt
11135000
Long Term Debt
-
Total Liabilities
103815000
Equity
82105000
Depreciation
3217000
Change In Working Capital
-2328000
Cash From Operations
-225000
Capital Expenditures
180000
Cash From Investing
-180000
Cash From Financing
-2379000
Net Change In Cash
-2784000
PE
-
PB
1.906408128615797
ROE
-11.58516533706839
ROA
-5.116179001721171
FCF
-405000
Fcf Percent
-0.01157374332009259
Piotroski FScore
1
Health Score
25
Deep Value Investing Score
1.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
34993000
Quarters > 0 > income Statement > cost Of Revenue
12064000
Quarters > 0 > income Statement > gross Profit
22929000
Quarters > 0 > income Statement > operating Expenses
32679000
Quarters > 0 > income Statement > operating Income
-9750000
Quarters > 0 > income Statement > interest Expense
1407000
Quarters > 0 > income Statement > pretax Income
-7867001
Quarters > 0 > income Statement > net Income
-9512000
Quarters > 0 > income Statement > eps
-0.15800095175972811
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
60202169
Quarters > 0 > income Statement > income Tax Expense
1644999
Quarters > 0 > income Statement > EBITDA
-3243001
Quarters > 0 > income Statement > operating Margin
-27.862715400222903
Quarters > 0 > income Statement > total Other Income Expense Net
1882999
Quarters > 0 > balance Sheet > cash
5405000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
12218000
Quarters > 0 > balance Sheet > property Plant Equipment
50582000
Quarters > 0 > balance Sheet > total Assets
185920000
Quarters > 0 > balance Sheet > payables
4460000
Quarters > 0 > balance Sheet > short Term Debt
11135000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
103815000
Quarters > 0 > balance Sheet > equity
82105000
Quarters > 0 > cash Flow > net Income
-9512000
Quarters > 0 > cash Flow > depreciation
3217000
Quarters > 0 > cash Flow > change In Working Capital
-2328000
Quarters > 0 > cash Flow > cash From Operations
-225000
Quarters > 0 > cash Flow > capital Expenditures
180000
Quarters > 0 > cash Flow > cash From Investing
-180000
Quarters > 0 > cash Flow > cash From Financing
-2379000
Quarters > 0 > cash Flow > net Change In Cash
-2784000
Quarters > 0 > ratios > PE
-0.15800095175972811
Quarters > 0 > ratios > PB
1.906408128615797
Quarters > 0 > ratios > ROE
-11.58516533706839
Quarters > 0 > ratios > ROA
-5.116179001721171
Quarters > 0 > ratios > FCF
-405000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.01157374332009259
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
44012000
Quarters > 1 > income Statement > cost Of Revenue
15501000
Quarters > 1 > income Statement > gross Profit
28511000
Quarters > 1 > income Statement > operating Expenses
27725000
Quarters > 1 > income Statement > operating Income
786000
Quarters > 1 > income Statement > interest Expense
1562000
Quarters > 1 > income Statement > pretax Income
-776000
Quarters > 1 > income Statement > net Income
-591000
Quarters > 1 > income Statement > eps
-0.010005688513266426
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
59066400
Quarters > 1 > income Statement > income Tax Expense
-185000
Quarters > 1 > income Statement > EBITDA
4139999
Quarters > 1 > income Statement > operating Margin
1.7858765791147868
Quarters > 1 > income Statement > total Other Income Expense Net
-1562000
Quarters > 1 > balance Sheet > cash
8189000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1805000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
16405000
Quarters > 1 > balance Sheet > property Plant Equipment
55368000
Quarters > 1 > balance Sheet > total Assets
198367000
Quarters > 1 > balance Sheet > payables
3337000
Quarters > 1 > balance Sheet > short Term Debt
10605000
Quarters > 1 > balance Sheet > long Term Debt
53188000
Quarters > 1 > balance Sheet > total Liabilities
107210000
Quarters > 1 > balance Sheet > equity
91157000
Quarters > 1 > cash Flow > net Income
-591000
Quarters > 1 > cash Flow > depreciation
3246000
Quarters > 1 > cash Flow > change In Working Capital
733000
Quarters > 1 > cash Flow > cash From Operations
4984000
Quarters > 1 > cash Flow > capital Expenditures
265000
Quarters > 1 > cash Flow > cash From Investing
-265000
Quarters > 1 > cash Flow > cash From Financing
-2083000
Quarters > 1 > cash Flow > net Change In Cash
2636000
Quarters > 1 > ratios > PE
-0.010005688513266426
Quarters > 1 > ratios > PB
1.6847048498743926
Quarters > 1 > ratios > ROE
-0.6483319986397096
Quarters > 1 > ratios > ROA
-0.2979326198410018
Quarters > 1 > ratios > FCF
4719000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.1072207579750977
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
39371000
Quarters > 2 > income Statement > cost Of Revenue
14150000
Quarters > 2 > income Statement > gross Profit
25221000
Quarters > 2 > income Statement > operating Expenses
26810000
Quarters > 2 > income Statement > operating Income
-1589000
Quarters > 2 > income Statement > interest Expense
1625000
Quarters > 2 > income Statement > pretax Income
-3214000
Quarters > 2 > income Statement > net Income
-2847000
Quarters > 2 > income Statement > eps
-0.04863590549566941
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
58537000
Quarters > 2 > income Statement > income Tax Expense
-367000
Quarters > 2 > income Statement > EBITDA
1653000
Quarters > 2 > income Statement > operating Margin
-4.035965558405933
Quarters > 2 > income Statement > total Other Income Expense Net
-1625000
Quarters > 2 > balance Sheet > cash
5553000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
3364000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
15298000
Quarters > 2 > balance Sheet > property Plant Equipment
58961000
Quarters > 2 > balance Sheet > total Assets
203260000
Quarters > 2 > balance Sheet > payables
4136000
Quarters > 2 > balance Sheet > short Term Debt
10329000
Quarters > 2 > balance Sheet > long Term Debt
69263000
Quarters > 2 > balance Sheet > total Liabilities
125927000
Quarters > 2 > balance Sheet > equity
77333000
Quarters > 2 > cash Flow > net Income
-2847000
Quarters > 2 > cash Flow > depreciation
3242000
Quarters > 2 > cash Flow > change In Working Capital
-872000
Quarters > 2 > cash Flow > cash From Operations
868000
Quarters > 2 > cash Flow > capital Expenditures
1901000
Quarters > 2 > cash Flow > cash From Investing
-1901000
Quarters > 2 > cash Flow > cash From Financing
-1649000
Quarters > 2 > cash Flow > net Change In Cash
-2682000
Quarters > 2 > ratios > PE
-0.04863590549566941
Quarters > 2 > ratios > PB
1.9680627933741093
Quarters > 2 > ratios > ROE
-3.6814813856956277
Quarters > 2 > ratios > ROA
-1.400669093771524
Quarters > 2 > ratios > FCF
-1033000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.026237586040486652
Quarters > 2 > health Score
26
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
39178000
Quarters > 3 > income Statement > cost Of Revenue
15047000
Quarters > 3 > income Statement > gross Profit
24131000
Quarters > 3 > income Statement > operating Expenses
28262000
Quarters > 3 > income Statement > operating Income
-4131000
Quarters > 3 > income Statement > interest Expense
1609000
Quarters > 3 > income Statement > pretax Income
-5740000
Quarters > 3 > income Statement > net Income
-5034000
Quarters > 3 > income Statement > eps
-0.08661241203695738
Quarters > 3 > income Statement > dividends Per Share
238000
Quarters > 3 > income Statement > shares Outstanding
58121000
Quarters > 3 > income Statement > income Tax Expense
-706000
Quarters > 3 > income Statement > EBITDA
-924000
Quarters > 3 > income Statement > operating Margin
-10.544182959824392
Quarters > 3 > income Statement > total Other Income Expense Net
-1609000
Quarters > 3 > balance Sheet > cash
8235000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
3056000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
17117000
Quarters > 3 > balance Sheet > property Plant Equipment
63140000
Quarters > 3 > balance Sheet > total Assets
209996000
Quarters > 3 > balance Sheet > payables
6256000
Quarters > 3 > balance Sheet > short Term Debt
10349000
Quarters > 3 > balance Sheet > long Term Debt
70456000
Quarters > 3 > balance Sheet > total Liabilities
130706000
Quarters > 3 > balance Sheet > equity
79290000
Quarters > 3 > cash Flow > net Income
-5034000
Quarters > 3 > cash Flow > depreciation
3188000
Quarters > 3 > cash Flow > change In Working Capital
2457000
Quarters > 3 > cash Flow > cash From Operations
2713000
Quarters > 3 > cash Flow > capital Expenditures
3528000
Quarters > 3 > cash Flow > cash From Investing
-3528000
Quarters > 3 > cash Flow > cash From Financing
3078000
Quarters > 3 > cash Flow > net Change In Cash
2263000
Quarters > 3 > ratios > PE
-0.08661241203695738
Quarters > 3 > ratios > PB
1.9058468911590365
Quarters > 3 > ratios > ROE
-6.348846008323875
Quarters > 3 > ratios > ROA
-2.397188517876531
Quarters > 3 > ratios > FCF
-815000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.02080249119403747
Quarters > 3 > health Score
26
Valuation > metrics > PE
-0.15800095175972811
Valuation > metrics > PB
1.906408128615797
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-11.58516533706839
Profitability > metrics > ROA
-77.85234899328859
Profitability > metrics > Net Margin
-0.2718257937301746
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.2644175141586993
Risk > metrics > Interest Coverage
-6.929637526652452
Risk > final Score
2
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.7834562359730682
Liquidity > metrics > Quick Ratio
0.7834562359730682
Liquidity > final Score
49
Liquidity > verdict
Weak
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
32
Prev Risks > 1
26
Prev Risks > 2
20
Prev Liquidities > 0
79
Prev Liquidities > 1
76
Prev Liquidities > 2
76
Updated At
2025-12-14T00:12:46.991Z
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AQuadrant Televentures Limited Recovery Potential Based on Technical Tools - Insider Trading Activity & Free Real-Time Trading Signals earlytimes.in
Read more →$AIRS stock is down 8% today. Here's what we see in our data. Quiver Quantitative
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$6
Analyst Picks
Strong Buy
0
Buy
0
Hold
4
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 66.17% of the total shares of Airsculpt Technologies Inc
1.
Vesey Street Capital Partners, L.L.C.(48.5679%)
since
2025/06/30
2.
SW Investment Management LLC(7.2073%)
since
2025/06/30
3.
Balyasny Asset Management LLC(1.784%)
since
2025/06/30
4.
BlackRock Inc(1.2741%)
since
2025/06/30
5.
Vanguard Group Inc(1.1311%)
since
2025/06/30
6.
ExodusPoint Capital Management, LP(1.0085%)
since
2025/06/30
7.
UBS Group AG(0.6825%)
since
2025/06/30
8.
FourWorld Capital Management LLC(0.6132%)
since
2025/06/30
9.
Millennium Management LLC(0.5475%)
since
2025/06/30
10.
Geode Capital Management, LLC(0.5274%)
since
2025/06/30
11.
Citigroup Inc(0.495%)
since
2025/06/30
12.
Monashee Investment Management LLC(0.3933%)
since
2025/06/30
13.
State Street Corp(0.3813%)
since
2025/06/30
14.
CenterBook Partners LP(0.3568%)
since
2025/06/30
15.
Divisadero Street Capital Management, LP(0.2654%)
since
2025/06/30
16.
Citizens Financial Group Inc(0.2369%)
since
2025/06/30
17.
Goldman Sachs Group Inc(0.1917%)
since
2025/06/30
18.
MATAURO, LLC(0.1845%)
since
2025/06/30
19.
Charles Schwab Investment Management Inc(0.1644%)
since
2025/06/30
20.
Wexford Capital LP(0.1602%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.